System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Evan L Brittain is an expert in Cardiology at Vanderbilt University Medical Center (United States). As of October 2026, ScienceLeadR ranks Evan L Brittain in the top 1% of experts worldwide for Hypertension and Hypertension, Pulmonary. Evan L Brittain has authored 290 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 3 of them ongoing. SLR score: 2,006 (community average: 125). How the SLR is computed.

LeadR Profile

Evan L Brittain Vanderbilt University Medical Center United States
2 006 ScienceLeadR Reputation 2006

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Pulmonology - Public Health - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2012 - 2026
Source: PubMed

Vanderbilt University Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 290

Citations

Citations: 5 694 1st author: 34 Last author: 103 Unique author: 2

Main journals

Circulation 40
Pulm Circ 37
J Am Coll Cardiol 31
Chest 16
Am J Respir Crit Care Med 11

Best Journals

Circulation 23
Nat Med 3
Eur Heart J 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Pathogenic variants in myoferlin ( MYOF) cause arrhythmogenic cardiomyopathy.
PMID 42818195 — genes, arrhythmias, cardiac, calcium, cardiomyopathies, myocytes, cardiac		medRxiv20260
Disentangling Pulmonary Vascular Phenotypes in Group 2 Pulmonary Hypertension Using Bioactive Lipid Profiling.
PMID 42717879 — hypertension, endothelium, vascular, hypertension, pulmonary, heart failure, phenotype, metabolomics		Circ Heart Fail20260
Data distribution impacts the performance and generalisability of contrastive learning-based foundation models of electrocardiograms.
PMID 42685022 — health status, foundations, learning, demography		PLOS Digit Health20261
Incidence and Clinical Associations With Phenotypic Drift From Pulmonary Arterial Hypertension to Combined Precapillary and Postcapillary Pulmonary Hypertension.
PMID 42548420 — hypertension, hypertension, pulmonary, hospitalization, capillaries, incidence, heart, atrial fibrillation, pulmonary arterial hypertension, hemodynamics		CHEST Pulm20251
A Case of High Pressure and High Stakes: Pulmonary Arterial Hypertension Emergence in an Infant With Hereditary Hemorrhagic Telangiectasia.
PMID 42516693 — genes, hypertension, activin receptors, telangiectasia, hereditary hemorrhagic, telangiectasis, pulmonary arterial hypertension, mutation, infant		Pulm Circ20260

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6

By phase:

N/A 8
Phase 2 2
Early Phase 1 1
Phase 3 1

By status:

Completed 5
Recruiting 5
Active not recruiting 2

By type:

Interventional 7
Observational 5

By Monocentric/Multicentric:

monocentric 10
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Mechanistic Study of Nicotinamide Riboside on NAD Biology in Individuals With Combined Pulmonary Hypertension
NCT07563322 — cells, hypertension, lung, hypertension, pulmonary, blood, niacinamide, heart failure, heart, nad, therapeutics, blood vessels		N/ARecruiting2026
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
NCT05464095 — exercise, hypertension, quality of life, health insurance portability and accountability act, insurance, insurance, health, reward, pulmonary arterial hypertension, smartphone, lunch, text messaging, therapeutics		N/ARecruiting2023
Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)
NCT05462574 — familial primary pulmonary hypertension, hypertension, hypertension, pulmonary, connective tissue, connective tissue diseases, pulmonary arterial hypertension, tissues, lipids		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS